152 Followers on Owler

Leo Pharma

LEO Pharma is a biopharmaceutical company that develops drugs for dermatologic and thrombotic patients. Read more

Catherine Mazzacco's photo - President & CEO of Leo Pharma

President & CEO

Catherine Mazzacco

CEO Approval Rating

84/100

Founded:

1908

Status:

PrivateIndependent Company

LEO PHARMA TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Emergent BioSolutions is Leo Pharma's #1 competitor. Emergent BioSolutions was founded in Gaithersburg, Maryland} in 1998. Like Leo Pharma, Emergent BioSolutions also competes in the Pharmaceuticals industry. Compared to Leo Pharma, Emergent BioSolutions generates $111.6M more revenue.

F2G is one of Leo Pharma's top competitors. F2G was founded in 1998 in Manchester, England. Like Leo Pharma, F2G also operates in the Pharmaceuticals industry. F2G generates $1.6B less revenue than Leo Pharma.

BioMarin is a top competitor of Leo Pharma. BioMarin was founded in 1997, and is headquartered in San Rafael, California. Like Leo Pharma, BioMarin also competes in the Pharmaceuticals field. BioMarin generates $250.2M more revenue vs. Leo Pharma.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Novavax a competitor of Leo Pharma?

Leo Pharma Acquisitions

COMPANY ACQUIRED
ACQUISITION DATE
AMOUNT
DESCRIPTION

-

Global Prescription Derm Business, Bayer AG

Jul 2018

Source »
undisclosed
-

These are all the companies that Leo Pharma has acquired. Leo Pharma's latest acquisition was Global Prescription Derm Business, Bayer AG in Jul 2018.

Leo Pharma Funding History

Since Leo Pharma was founded in 1908, it has participated in 1 round of funding. In total Leo Pharma has raised $532.3M. Leo Pharma's funding round was on Mar 2021 for a total of $532.3M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Equity Round
Mar 2021
$532.3M

Nordic Capital

Since Leo Pharma was founded in 1908, it has participated in 1 round of funding. In total Leo Pharma has raised $532.3M. Leo Pharma's funding round was on Mar 2021 for a total of $532.3M

Leo Pharma Investments

COMPANY

DESCRIPTION

AMOUNT

INVESTMENT DATE

ROUND

EXIT DATE

PellePharm is a pharmaceutical company that researches and develops novel therapeutics for the treatment of dermatological diseases.
$70M
Nov 19, 2018
Equity
-
SkinVision focuses on developing a mobile application to detect melanoma skin cancer symptoms.
$7.6M
Jul 30, 2018
Equity
-
LEO Innovation Lab is engaged to improve the wellbeing of people living with psoriasis.
$65.3M
Jan 19, 2016
Equity
-

These are all the companies that Leo Pharma has invested in. Leo Pharma's latest investment was Global Prescription Derm Business, Bayer AG in Jul 2018.

Leo Pharma News

May 18, 2021FiercePharma

Leo takes topical JAK inhibitor into phase 3 eczema program

Leo takes topical JAK inhibitor into phase 3 eczema program ntaylor Tue, 05/18/2021 - 08:52... See more »
April 26, 2021Pharmabiz

EMA committee recommends marketing approval for LEO Pharma's Adtralza to treat adults with moderatetosevere atopic dermatitis

LEO Pharma A/S, a global leader in medical dermatology, announced that the Committee for Medicinal Pr... See more »
March 25, 2021Global Legal Chronicle

Nordic Capital's 450 Million Investment in Leo Pharma

Accura advised Nordic Capital, while Plesner has advised the LEO Foundation and LEO Pharma in connect... See more »
February 16, 2021Pharmacy Business

Kleinpeter is Leo Pharma's new VP for UK, Ireland

Danish pharmaceutical multinational Leo Pharma has appointed Sarah Kleinpeter as its UK and Ireland v... See more »
January 13, 2021MarketScreener

LEO Pharma initiates head-to-head study to evaluate brodalumab vs. guselkumab in adult patients with moderate-to-severe psoriasis who have inadequate response to ustekinumab

(marketscreener.com) The COBRA study is the first to compare an IL-17 receptor blocker with an IL-23 ... See more »
December 16, 2020The Pharma Letter

LEO Pharma lures former-Bayer exec to head R&D

Privately-held Danish medical dermatology specialist LEO Pharma today announced that Jörg Möller will... See more »
December 16, 2020MarketScreener

Strengthens Global Leadership Team With Appointment of Jrg Mller as Executive Vice President, Global Research and Development

(marketscreener.com) LEO Pharma A/S today announced that Jörg Möller will join its Global Leadership ... See more »
November 2, 2020Pharmafile

LEO Pharma's delgocitinib hits main goals in moderate-to-severe chronic hand eczema

LEO Pharma has revealed new Phase 2b at the European Academy of Dermatology and Venereology (EADV) Vi... See more »
October 22, 2020FiercePharma

Leo Pharma's dermatology innovation challenge gathers ideas focused on skin of color

Leo Pharma's dermatology innovation challenge gathers ideas focused on skin of color sharon.coey Thu,... See more »

Leo Pharma Press Releases

March 24, 2021Business Wire

LEO Pharma Delivered on Strategic Ambitions and Showed Resilience During COVID-19 Pandemic in 2020

BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma delivered on strategic ambitions and showed resilience... See more »
October 27, 2020Cision Canada

Information update - LEO Pharma Inc. is withdrawing the drug Picato (Ingenol mebutate), used to treat skin lesions, due to the potential increased risk of skin cancer

/CNW/ - Summary Product: Picato (ingenol mebutate) Issue: Using Picato may increase the risk of non-m... See more »
August 4, 2020Business Wire

LEO Pharma Announces U.S. Food and Drug Administration Fast Track Designation for delgocitinib Cream for the Treatment of Adults With Moderate-to-severe Chronic Hand Eczema

BALLERUP, Denmark & MADISON, N.J.--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermat... See more »
June 11, 2020Business Wire

LEO Pharma Announces European Medicines Agency Acceptance of Marketing Authorization Application for tralokinumab for the Treatment of Adults With Moderate-To-Severe Atopic Dermatitis

BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma A/S, a global leader in medical dermatology, today ann... See more »
November 7, 2019Business Wire

LEO Science & Tech Hub and Epicore Biosystems Announce Second Phase of Partnership Exploring Use of Wearable Skin Sensors to Improve Dermatologic Treatment Regimens

CAMBRIDGE, Mass.--(BUSINESS WIRE)--LEO Science & Tech Hub, the Boston-based R&D innovation unit of LE... See more »
October 24, 2019Business Wire

LEO Pharma Launches New Campaign to Reduce the Stigma Surrounding Psoriasis

BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma, a global leader in medical dermatology, announced tha... See more »
September 13, 2018Business Wire

LEO Pharma to Showcase Two Dozen Data Presentations at 27th Annual European Academy of Dermatology and Venerology Congress in Paris

BALLERUP, Denmark--(BUSINESS WIRE)--LEO Pharma to showcase two dozen data presentations at 27th annua... See more »
April 11, 2018econotimes

argenx to receive third preclinical milestone payment from collaboration with LEO Pharma - Milestone associated with CTA approval for ARGX-112

argenx (Euronext & Nasdaq: ARGX) a clinical-stage biotechnology company developing a deep pipeline of... See more »
October 16, 2017GlobalNewswire

U.S. Ranks Seventh in First-Ever World Psoriasis Happiness Report

First report of its kind reveals how gender, social isolation, and doctor relationships affect people... See more »

Leo Pharma Videos

June 15, 2018Leo Pharma Youtube Channel

"Pharmacists' role in CAT management" on YOUTUBE

June 15, 2018Leo Pharma Youtube Channel

"Managing CAT patients is complex" on YOUTUBE

April 20, 2018Leo Pharma Youtube Channel

"What is LEO Pharma Open Innovation?" on YOUTUBE

April 5, 2016Leo Pharma Youtube Channel

"Living with Cancer and Thrombosis" on YOUTUBE

December 16, 2015Leo Pharma Youtube Channel

"Itch Impacts Psoriasis Patients" on YOUTUBE

October 15, 2015LEO PHARMA YOUTUBE CHANNEL

"#DiscoverPsoriasis" on YOUTUBE

October 8, 2015LEO PHARMA YOUTUBE CHANNEL

"Applicator Instruction For Use Video" on YOUTUBE

Social Media

Leo Pharma Headquarters

Industriparken 55

Ballerup, Capital Region2750

454-494-5888

Driving Directions »

Trending Companies

Leo Pharma Summary

ABOUT

Overview

LEO Pharma is a biopharmaceutical company that develops drugs for dermatologic and thrombotic patients. Leo Pharma was founded in 1908. Leo Pharma's headquarters is located in Ballerup, Capital Region, DK 2750. It has raised 532.3M in 1 round. The lat...

CEO

Leo Pharma's President & CEO, Catherine Mazzacco, currently has an approval rating of 84%. Leo Pharma's primary competitors are Emergent BioSolutions, F2G & BioMarin.

Frequently Asked Questions about Leo Pharma

  1. When was Leo Pharma founded?

    Leo Pharma was founded in 1908
  2. Who is Leo Pharma's CEO?

    Leo Pharma's CEO is Catherine Mazzacco
  3. How much revenue does Leo Pharma generate?

    Leo Pharma generates $1.6B in revenue
  4. How much funding does Leo Pharma have?

    Leo Pharma has historically raised $532.3M in funding
  5. Where is Leo Pharma's headquarters?

    Leo Pharma's headquarters is in Ballerup Capital Region, DK
  1. How many employees does Leo Pharma have?

    Leo Pharma has 6,000 employees
  2. What sector does Leo Pharma operate in?

    Leo Pharma is in Pharmaceuticals
  3. Who are Leo Pharma's competitors?

    Leo Pharma's top competitors are Emergent BioSolutions, F2G, BioMarin
  4. Who has Leo Pharma invested in?

    Leo Pharma's has invested in companies such as PellePharm, SkinVision B.V., LEO Innovation Lab